Strike Pharma is developing in vivo CAR-T therapies for autoimmune disease and cancer based on a proprietary technology for targeted LNP delivery.
Learn more about our science here:
Strike Pharma is developing in vivo CAR-T therapies for autoimmune disease and cancer based on a proprietary technology for targeted LNP delivery.
Learn more about our science here: